Ozempic/Wegovy Tracker App
Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
What Is Ozempic/Wegovy?
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Ozempic/Wegovy protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Ozempic/Wegovy protocol record from day one.
How to Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy Key Facts
Protocol FAQs
Yes! Shotlee fully supports compounded semaglutide with custom dosing. Enter any mg amount and track vials, reconstitution, and more.
Absolutely! Shotlee supports Rybelsus daily tablet tracking with 3mg, 7mg, and 14mg doses, plus reminders to take it on an empty stomach.
Log each injection with your current dose. Shotlee shows your dose history and helps you track your titration schedule from starting to maintenance dose.
Open the Shotlee app, navigate to the dose logging screen, select Semaglutide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Ozempic/Wegovy Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semaglutide
Peptides and Health: The Truth Behind the Beauty and Weight Loss Claims
Peptides are the newest buzzword in health and beauty, promising everything from wrinkle reduction to profound weight loss. But does the science actually back up the claims, and are they safe?
7 min read
Svemia Approved: What Canada's New Semaglutide Generic Means for You
Canada's Health Department has cleared Apotex's Svemia, marking a major milestone for generic semaglutide availability and weight loss treatment access.
7 min read
Navigating Medicare's New Path for GLP-1 Weight Loss Coverage
For years, Medicare coverage for GLP-1 medications like Ozempic and Wegovy was strictly limited to diabetes management. A significant shift is underway, however, as a new 'Bridge' program opens doors for weight loss coverage, albeit with specific requirements and nuances that patients must navigate.
6 min read